| Product Code: ETC10797324 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Pharmacogenomics Technology Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Pharmacogenomics Technology Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Pharmacogenomics Technology Market - Industry Life Cycle |
3.4 Netherlands Pharmacogenomics Technology Market - Porter's Five Forces |
3.5 Netherlands Pharmacogenomics Technology Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 Netherlands Pharmacogenomics Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Netherlands Pharmacogenomics Technology Market Revenues & Volume Share, By Testing Method, 2021 & 2031F |
3.8 Netherlands Pharmacogenomics Technology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Netherlands Pharmacogenomics Technology Market Revenues & Volume Share, By Market Driver, 2021 & 2031F |
3.9.1 Increasing demand for personalized medicine |
3.9.2 Technological advancements in pharmacogenomics |
3.9.3 Growing awareness and adoption of precision medicine practices in healthcare |
4 Netherlands Pharmacogenomics Technology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
4.3.1 High cost associated with pharmacogenomics technology |
4.3.2 Regulatory challenges and compliance issues |
4.3.3 Limited availability of skilled professionals in pharmacogenomics |
5 Netherlands Pharmacogenomics Technology Market Trends |
6 Netherlands Pharmacogenomics Technology Market, By Types |
6.1 Netherlands Pharmacogenomics Technology Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Technology Type, 2021 - 2031F |
6.1.3 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Genotyping, 2021 - 2031F |
6.1.4 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031F |
6.1.5 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Gene Expression Profiling, 2021 - 2031F |
6.1.6 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Bioinformatics Solutions, 2021 - 2031F |
6.1.7 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Companion Diagnostics, 2021 - 2031F |
6.2 Netherlands Pharmacogenomics Technology Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.2.3 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Drug Response Analysis, 2021 - 2031F |
6.2.4 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Oncology Treatment, 2021 - 2031F |
6.2.5 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Adverse Drug Reactions, 2021 - 2031F |
6.2.6 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
6.3 Netherlands Pharmacogenomics Technology Market, By Testing Method |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.3.3 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Microarray, 2021 - 2031F |
6.3.4 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Whole Genome Sequencing, 2021 - 2031F |
6.3.5 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By AI-Based Analytics, 2021 - 2031F |
6.3.6 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By DNA Microarray, 2021 - 2031F |
6.4 Netherlands Pharmacogenomics Technology Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Pharma Companies, 2021 - 2031F |
6.4.3 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.4 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Research Labs, 2021 - 2031F |
6.4.5 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Academic Institutions, 2021 - 2031F |
6.4.6 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.5 Netherlands Pharmacogenomics Technology Market, By Market Driver |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Advancements in Precision Medicine, 2021 - 2031F |
6.5.3 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Increase in Genetic Testing, 2021 - 2031F |
6.5.4 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Growing Interest in Targeted Therapy, 2021 - 2031F |
6.5.5 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Expansion in Pharmacovigilance, 2021 - 2031F |
6.5.6 Netherlands Pharmacogenomics Technology Market Revenues & Volume, By Demand for Tailored Therapeutics, 2021 - 2031F |
7 Netherlands Pharmacogenomics Technology Market Import-Export Trade Statistics |
7.1 Netherlands Pharmacogenomics Technology Market Export to Major Countries |
7.2 Netherlands Pharmacogenomics Technology Market Imports from Major Countries |
8 Netherlands Pharmacogenomics Technology Market Key Performance Indicators |
8.1 Rate of adoption of pharmacogenomics technology in healthcare institutions |
8.2 Number of research studies and clinical trials utilizing pharmacogenomics technology |
8.3 Investment in RD for new pharmacogenomics solutions |
8.4 Number of partnerships and collaborations between pharmaceutical companies and pharmacogenomics technology providers |
9 Netherlands Pharmacogenomics Technology Market - Opportunity Assessment |
9.1 Netherlands Pharmacogenomics Technology Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 Netherlands Pharmacogenomics Technology Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Netherlands Pharmacogenomics Technology Market Opportunity Assessment, By Testing Method, 2021 & 2031F |
9.4 Netherlands Pharmacogenomics Technology Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Netherlands Pharmacogenomics Technology Market Opportunity Assessment, By Market Driver, 2021 & 2031F |
10 Netherlands Pharmacogenomics Technology Market - Competitive Landscape |
10.1 Netherlands Pharmacogenomics Technology Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Pharmacogenomics Technology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here